Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 18Neoplasms 14Breast Neoplasms 13Neuroendocrine Tumors 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 6Stomach Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Pancreatic Neoplasms 4Multiple Myeloma 4Disease 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Mouth Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Head and Neck Neoplasms 3Glioma 3Esophageal Squamous Cell Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Cells, Circulating 2Nasopharyngeal Carcinoma 2Multiple Pulmonary Nodules 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Liver Neoplasms 2Leukemia 2

Interventions

Electrochemotherapy 2sintilimab 1regorafenib 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Metastases × Positron Emission Tomography Computed Tomography × Clear all
NCT04143516 2026-03-19

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Memorial Sloan Kettering Cancer Center

Phase 2/3 Recruiting
200 enrolled

Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡